Jean‐Philippe ChippauxA. N. Salas-ClavijoJorge R. PostigoDominique SchneiderJosé-Antonio SantallaLaurent Brutus2026-03-222026-03-22201210.1093/trstmh/trs004https://doi.org/10.1093/trstmh/trs004https://andeanlibrary.org/handle/123456789/45273Citaciones: 27The short treatment should be preferred as it allows reducing the dose of benznidazole as well as the cost of treatment.enBenznidazoleMedicineChagas diseaseClinical trialSerologyRandomized controlled trialInternal medicineGroup BPediatricsSurgeryEvaluation of compliance to congenital Chagas disease treatment: results of a randomised trial in Boliviaarticle